Increasing Access to Naloxone and Legal Issues

M. Gabay

DOI: https://doi.org/10.1310/HPJ5108-633

2016-09-01

Hospital Pharmacy

Abstract:

What problem does this paper attempt to address?

Bone metabolism and insulin resistance in obese children

HUANG Yao,FU Jun-fen,LI Yun,LIANG Li,WANG Chun-lin,LI Le-fei,DONG Wen-mei

DOI: https://doi.org/10.3969/j.issn.1000-3606.2009.02.015

2009-01-01

Abstract:Objectives To investigate the relationship between bone mineral density(BMD) together with metabolism of bone and insulin resistance(IR) in pathogenesis of obesity in boys.Methods Speed of ultrasound of distal radius was detected in 70 obese boys(from 7 to 14 years old) of body mass index(BMI) over 23 and 20 healthy controls with age and sex matched to evaluate their BMD.Blood calcium(Ca),phosphorus(P),alkaline phosphatase(ALP),free blood glucose(FBG),free insulin(FINS),osteocalcin(OC) and parathyroid hormone(PTH) were also detected.Homeostasis model assessment was applied to assess the status of IR(IR = FBG × FINS/22.5) and basicβ-cell secretion function of the pancrease [IS = 20 × FINS /(FBG-3.5)].Results The level of BMD and OC in obese boys with BMI over 25 were significantly lower than that of controls(P < 0.01).While free blood sugar,FINS,IR,free PTH and ALP were significantly higher than that of controls(P < 0.01) ;bivariate correlation analysis showed that BMD is negatively associated with BMI,FINS and IR(r =-0.5,rs =-0.58,rs =-0.6,P < 0.01),and positively associated with OC(r = 0.63,P < 0.01).Conclusions Abnormal bone metabolism existed in severe obese boys whose low bone mass were highly associated with degree of obesity,hyperinsulinemia and IR.
[Isolation of an anti-rickets compound formed during the action of floridin on cholesterol].

Y. Raoul,N. Le Boulch,C. Baron,J. Chopin,A. Guerillot-Vinet

Abstract:
Contrasting Bone Profiles in PCOS Are Related to BMI: A Systematic Review and Meta-analysis

Graziela Rissetti,Julia Mottecy Piovezan,Melissa Orlandin Premaor,Fabio Vasconcellos Comim

DOI: https://doi.org/10.1210/clinem/dgae325

2024-05-13

The Journal of Clinical Endocrinology & Metabolism

Abstract:Abstract Context Controversial results have emerged regarding whether polycystic ovary syndrome (PCOS) is protective or increases the risk of bone frailty. Objective This study investigated whether the PCOS condition affects bone parameters of premenopausal women. This is an update for a previous meta-analysis published in 2019. Data Sources We searched MEDLINE and Embase. Study Selection Studies were considered eligible for the update if published in English between October 1, 2018, and December 31, 2023. The diagnosis of PCOS should be based on National Institutes of Health criteria, the Rotterdam Consensus, Androgen Excess & PCOS Society criteria, or International Classification of Diseases codes in women over 18 years old. Only records with the Newcastle-Ottawa Scale ≥ 6 were selected for data extraction. Data Extraction Data were extracted by 2 independent reviewers. Data Synthesis We identified 31 studies that met the inclusion criteria for qualitative analysis from 3322 studies in the whole period (1990-2023). Overall, cross-sectional studies included 1822 individuals with PCOS and 1374 controls, while cohort studies incorporated 30 305 women with PCOS and 10,1907 controls. Contrasting profiles emerged after stratification using a body mass index (BMI) cutoff of 27 kg/m2. Individuals with PCOS and a BMI <27 kg/m2 exhibited lower vertebral and nonvertebral bone density, reduced bone turnover marker (osteocalcin), and increased bone resorption marker (C-terminal type I collagen) levels. Conversely, individuals with PCOS and a BMI ≥27 kg/m2 exhibited increased vertebral and nonvertebral bone mineral density, with no significant changes in bone formation and resorption markers (except osteocalcin). Conclusion The findings of this study alert for a low bone mass, low bone formation, and increased bone resorption PCOS with a BMI <27 kg/m2.

endocrinology & metabolism
Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome

Burcu Çelik Eroğlu,Levend Karaçoban,Ilkay S. Idılman,Feza Korkusuz,Bulent Okan Yıldız

DOI: https://doi.org/10.1016/j.maturitas.2024.107982

IF: 5.11

2024-04-02

Maturitas

Abstract:Objective The potential effects of polycystic ovary syndrome (PCOS) on the musculoskeletal system are not well established. We examined the musculoskeletal system in women with PCOS in their late reproductive years. Study-design This cross-sectional study included 34 women with PCOS and 32 control women matched for age and body mass index (BMI). Main outcome measures Dual-energy x-ray absorptiometry (DXA) was used for body composition analysis and cross-sectional areas and fat fraction of muscles were assessed by magnetic resonance imaging-proton density fat fraction (MRI-PDFF) of the abdomen and thigh. Muscle strength was measured using an isokinetic dynamometer. Results The mean age of the PCOS group was 43 ± 3.7 years and of the control group 42.2 ± 3.5 years. Testosterone, free androgen index, and fasting insulin were higher in PCOS patients than controls ( p < 0.001, p = 0.001 and p = 0.032, respectively). Patients and controls had similar values for total abdominal muscle area (TAMA), paraspinal muscle area, thigh muscle area, vertebral MRI-PDFF, thigh and paraspinal muscle MRI-PDFF. There was no difference in DXA-derived muscle and bone composition between the two groups. Body composition parameters measured by MRI and DXA were correlated with BMI and fasting insulin levels, but not with androgen levels in both groups. Subgroup analyses showed that PCOS women with obesity had higher TAMA than controls with obesity ( p = 0.012). Apart than higher 60°/sec knee extensor average power in nonobese PCOS ( p = 0.049), no difference in muscle mechanical function was detected between PCOS patients and controls. Conclusion Musculoskeletal composition and function are similar in PCOS patients and healthy women in late reproductive years. Body composition is linked with obesity and insulin resistance rather than hyperandrogenemia.

obstetrics & gynecology,geriatrics & gerontology,gerontology
Altered Vitamin D Status and Bone Mineral Density in Obese and Non-obese Patients With Polycystic Ovary Syndrome: A Cross-Sectional Study in Turkey

Ayşen Akkurt Kocaeli

DOI: https://doi.org/10.7759/cureus.50464

2023-12-13

Cureus

Abstract:Background Polycystic ovary syndrome (PCOS) is the most common endocrinological disease in women of reproductive age. In addition to providing the basis for comorbidities such as metabolic and cardiovascular diseases, it also affects bone metabolism. This study aimed to determine whether there is a relationship between bone mineral density (BMD), vitamin D status, insulin resistance, sex hormones, and calcium metabolism disorders in women with PCOS. Methodology Fifty-six non-obese women with PCOS, 67 obese women with PCOS, and 45 normal weight controls participated in the study. Circulating levels of gonadotropins, estradiol, prolactin, dehydroepiandrosterone sulfate, total testosterone, thyroid stimulating hormone, sex hormone-binding globulin, insulin, glucose, and calcium metabolism parameters were assessed. We used the Homeostatic Model Assessment-Insulin Resistance Index to detect insulin resistance. BMD values in the various body regions were measured by dual X-ray absorptiometry. Results Women with PCOS had significantly lower vitamin D values and lumbar spine BMD than controls (p <0.001 and p <0.05, respectively). Among the patients with PCOS subgroups, vitamin D deficiency (VDD) was more frequent in obese PCOS patients (67.1%) than in non-obese patients (58.9%). We found significantly lower BMD at all sites only in the subgroup of the non-obese PCOS women than in controls (p <0.001). Conclusions VDD is prevalent in PCOS women in those with obesity and hyperandrogenemia. Non-obese PCOS women have significantly lower BMD measurements than healthy controls, but obese PCOS women have BMD values comparable with normal-weight eumenorrheic controls. Body mass index is the most important factor determining BMD in women with PCOS.
Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health

Edouard G Mills,Ali Abbara,Waljit S Dhillo,Alexander N Comninos

DOI: https://doi.org/10.3389/fendo.2023.1163771

2023-05-12

Abstract:Polycystic Ovary Syndrome (PCOS) is a highly prevalent and heterogenous endocrinopathy affecting 5-18% of women. Although its cardinal features include androgen excess, ovulatory dysfunction, and/or polycystic ovarian morphology, women often display related metabolic manifestations, including hyperinsulinaemia, insulin resistance, and obesity. Emerging data reveal that the hormonal alterations associated with PCOS also impact bone metabolism. However, inconsistent evidence exists as to whether PCOS is a bone-protective or bone-hindering disorder with an accumulating body of clinical data indicating that hyperandrogenism, hyperinsulinaemia, insulin resistance, and obesity may have a relative protective influence on bone, whereas chronic low-grade inflammation and vitamin D deficiency may adversely affect bone health. Herein, we provide a comprehensive assessment of the endocrine and metabolic manifestations associated with PCOS and their relative effects on bone metabolism. We focus principally on clinical studies in women investigating their contribution to the alterations in bone turnover markers, bone mineral density, and ultimately fracture risk in PCOS. A thorough understanding in this regard will indicate whether women with PCOS require enhanced surveillance of bone health in routine clinical practice.
Marrow adipose tissue is increased in overweight and obese women with PCOS independently of hyperandrogenism related obesity and metabolic disorders

Li Xu,Min Min,Xintong Li,Glen M. Blake,Kaiping Zhao,Xiangyan Ruan,Xiaoguang Cheng

DOI: https://doi.org/10.3389/fendo.2023.1168806

IF: 6.055

2023-01-01

Frontiers in Endocrinology

Abstract:PurposeThis study aimed to investigate the increase in bone marrow adipose tissue (BMAT) in overweight and obese women with polycystic ovary syndrome (PCOS) and its relationship with hyperandrogenism, obesity, and metabolic disorders. MethodsThe study included 87 overweight or obese women with PCOS (mean age 29 +/- 4 years), as well as 87 age-matched controls recruited from a separate population study. All PCOS patients were measured for anthropometric features, abdominal adipose tissue areas, BMAT, biochemistry, and sex hormones. BMAT was compared between the PCOS patients and controls. In PCOS patients, subgroup comparisons of BMAT and its associations with body adiposity indices, biochemistry, and sex hormones were analyzed. The odds ratios (ORs) of elevated BMAT (defined as BMAT >= 38%) were calculated. ResultsOn average BMAT was increased by 5.6% ( +/- 11.3%) in PCOS patients compared to controls. BMAT were significantly higher in the upper tertiles of total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C). BMAT was not correlated with abdominal adiposity indices or biochemistry except for LDL-C (r = 0.253-0.263, p = 0.014-0.018). LDL-C was not significantly different between the normal and abnormal androgen PCOS subgroups (p = 0.10-0.887). LDL-C, follicle stimulating hormone (FSH), and total testosterone (TT) were risk factors for elevated BMAT, with ORs of 1.899 (p = 0.038-0.040), 1.369 (p = 0.030-0.042), and 1.002 (p = 0.040-0.044) for each unit increase, respectively. ConclusionBMAT was increased in overweight and obese PCOS patients, but the increase in BMAT was not associated with the hyperandrogenism related obesity or metabolic disorders.
Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis

Laurence J Dobbie,Bradley Pittam,Sizheng Steven Zhao,Uazman Alam,Theresa J Hydes,Thomas M Barber,Daniel J Cuthbertson

DOI: https://doi.org/10.1093/humrep/dead053

2023-06-01

Abstract:Study question: What is the influence of body composition during childhood, adolescence, and adulthood, as well as metabolic parameters, on incident polycystic ovary syndrome (PCOS)? Summary answer: Excess body fat, even during childhood/adolescence, and metabolic parameters, suggestive of hyperinsulinaemia/insulin resistance, significantly impact the risk of PCOS in a linear fashion. What is known already: Observational and Mendelian randomization (MR) data have demonstrated an association between adulthood overweight/obesity and development of PCOS. However, the contribution of body composition in childhood/adolescence to incident PCOS is unclear, as is the influence of childhood overweight/obesity. Study design, size, duration: We conducted a systematic review and meta-analysis and integrated our results with a previously published systematic review. Two blinded investigators screened abstracts published between November 2010 and May 2021. Furthermore, we incorporated summary statistics from genome-wide association study (GWAS) data in subjects of European ancestry. Adult overweight was defined as BMI ≥ 25 kg/m2 and obesity as BMI ≥ 30 kg/m2; in Asian subjects, overweight was defined as BMI ≥ 23 kg/m2 and obesity as BMI ≥ 25 kg/m2. Participants/materials, setting, methods: We utilized meta-analysis and MR together to allow synthesis of genetic and observational data. For the systematic review, the search revealed 71 studies, of which 63 were included in meta-analysis by calculating odds ratios (ORs) using the random-effects model. Furthermore, we conducted a two-sample MR study of GWAS data to determine the impact of childhood and adult body size (defined categorically by BMI and childhood body size proportions), abnormal body composition and metabolic parameters (higher fasting serum insulin or lower sex hormone-binding globulin (SHBG) concentration) on the odds of incident PCOS via the inverse-variance weighted method. Main results and the role of chance: Significant associations were shown between body composition and PCOS incidence. From the systematic review/meta-analysis, women with overweight (OR 3.80, 2.87-5.03), obesity (OR 4.99, 3.74-6.67), and central obesity (OR 2.93, 2.08-4.12) had increased odds of PCOS. For adolescents with overweight and/or obesity, the PCOS odds were greater than for adults. From MR, for every standard deviation increase in BMI (4.8 kg/m2), the odds of PCOS increased by 2.76 (2.27-3.35). Childhood body size had an independent effect on PCOS odds after adjusting for adult body size (OR: 2.56, 1.57-4.20). Genetically determined body fat percentage (OR 3.05, 2.24-4.15), whole body fat mass (OR 2.53, 2.04-3.14), fasting serum insulin (OR 6.98, 2.02-24.13), and SHBG concentration (OR 0.74, 0.64-0.87) were all significantly associated with PCOS in a linear relation. Limitations, reasons for caution: The meta-analysis included studies which were cross-sectional and retrospective, limiting our ability to determine causality. MR was limited by interrogating subjects only of European ancestry and including cases classified by either self-diagnosis or diagnostic criteria. Wider implications of the findings: Our study demonstrates for the first time a critical role of the impact of excess childhood/adolescent adiposity on the pathophysiology of adult PCOS. Our results, driven by genetically determined childhood/adolescent body composition, higher BMI, hyperinsulinaemia, and lower SHBG, clearly favour obesity driving the metabolic, but not reproductive, PCOS phenotype. Overall, effective weight maintenance, even from the early years, is likely to reduce the risk of this reproductive endocrine disorder. Study funding/competing interest(s): S.S.Z. was funded by a National Institute for Health and Care Research (NIHR) Academic Clinical Lectureship. U.A. is chair of the NIHR Steering Committee Trial-CASSANDRA-DN. No other authors declare any sources of funding or relevant conflicts of interest. The authors declare that the research was conducted in the absence of any commercial or financial relations that could be construed as a potential conflict of interest. Trial registration number: N/A.
Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome

Haolin Zhang,Wei Wang,Jiaming Zhao,Peijie Jiao,Lin Zeng,Hua Zhang,Yue Zhao,Li Shi,Hangqi Hu,Liyan Luo,Ii Fukuzawa,Dong Li,Rong Li,Jie Qiao

DOI: https://doi.org/10.3389/fendo.2022.1085656

IF: 6.055

2023-01-09

Frontiers in Endocrinology

Abstract:Objective To investigate how body fat influences glucose metabolism and hormone profiles in women with polycystic ovary syndrome (PCOS), compared to women without PCOS. Methods We conducted a cross-sectional study of 166 women with PCOS and 139 age-matched control women at Peking University Third Hospital (Beijing, China) from March 2016 to December 2021. All participants underwent bioimpedance rate assessment of clinical, anthropometric, hormonal, and metabolic features. In particular, body composition parameters were assessed, based on the methods used in a previous study. Homeostasis model assessment-insulin resistance (HOMA-IR) and other indices calculated from fasting glucose and insulin were used to measure insulin resistance. The hormonal profiles [follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen (E2), prolactin (PRL), total testosterone (T), and androstenedione (A2)] were assessed by using biochemical methods. Two subgroup analyses were conducted according to waist-to-hip ratio (WHR; < 0.85, non-central obesity and ≥ 0.85, central obesity) and body fat percentage (BFP; < 35% for lean and ≥35% for obesity). The indices above were analyzed using a two-sided t-test or Wilcoxon rank sum test. Linear regression was used to investigate the effects of body composition on metabolism and sex hormones in the PCOS and control groups. Results Compared to women without PCOS, women with PCOS and central obesity ( P =0.021), PCOS and noncentral obesity ( P <0.001), PCOS and high BFP ( P <0.001), and PCOS and low BFP ( P <0.001) had more severe glucose metabolism evaluated with HOMA-IR. Women with PCOS experienced greater insulin sensitivity impairment than did the normal population for every equal increase in BFP. LH, LH/FSH, total testosterone, and androstenedione were significantly higher in patients with PCOS than in healthy controls, regardless of WHR and BFP stratification. However, negative correlations existed between body fat indices (i.e., BFP and body mass index) and hormone indices (i.e., LH and androstenedione) in the PCOS group, but were absent in the control group. Conclusions Obese and non-obese women with PCOS have more severe insulin resistance and sex-hormone disorders than women without PCOS. The effect of body fat on sex-hormone disorders is only exist in women with PCOS. These findings suggested that PCOS clinical guidelines should be more specific to body fat. Clinical trial registration https://clinicaltrials.gov/ , Registration No. NCT04264832.

endocrinology & metabolism
Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome

Kara S Hughan,Hala Tfayli,Julia G Warren-Ulanch,Emma Barinas-Mitchell,Silva A Arslanian

DOI: https://doi.org/10.1016/j.jpeds.2015.09.082

Abstract:Objectives: Because in obese youth, pulse wave velocity (PWV), an early cardiovascular disease marker, is elevated, we tested if obese girls with polycystic ovary syndrome (OB-PCOS) have higher PWV and carotid intima-media thickness (cIMT) compared with obese girls without PCOS (OB-non-PCOS) and normal-weight girls without PCOS (NW-non-PCOS) and whether PWV and cIMT correlate with inflammatory and circulating endothelial function biomarkers. Study design: Cross-sectional study of PWV and cIMT in 91 OB-PCOS, 30 obese controls (OB-non-PCOS), and 19 normal-weight controls (NW-non-PCOS). Body composition, blood pressure, fasting glucose, insulin, lipid concentrations, and endothelial function biomarkers were measured. OB-non-PCOS and OB-PCOS underwent 2-hour oral glucose tolerance testing. Results: PWV was higher in OB-PCOS (664 ± 24 cm/s) and OB-non-PCOS (624 ± 37 cm/s) compared with NW-non-PCOS (468 ± 13 cm/s, P < .001), with no differences in cIMT. Systolic blood pressure, low-density lipoprotein, and non-high-density lipoprotein cholesterol were higher, and high-density lipoprotein cholesterol and indices of insulin sensitivity were lower in OB-PCOS and OB-non-PCOS compared with NW-non-PCOS. Vascular cell adhesion molecule-1 and high-sensitivity C-reactive protein were higher in OB-PCOS compared with NW-non-PCOS. PWV correlated with adiposity (rs = .46), insulin sensitivity index (homeostatic model assessment-insulin resistance rs = .31), systolic blood pressure (rs = .24; P ≤ .003 for all), and free testosterone (rs = .24; P = .03). In multiple regression analysis with PWV as the dependent variable and age, race, body mass index, PCOS, and dysglycemia as independent variables, only body mass index was an independent contributor to the model (r(2) = 0.068, P = .003). Conclusions: In adolescent girls, obesity and not PCOS appears to be associated with heightened cardiovascular disease risk. Increased PWV, vascular cell adhesion molecule-1, and high-sensitivity C-reactive protein may be the earliest subclinical atherosclerosis biomarkers in OB-PCOS.
Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome

Vered D. Lewy,Kapriel Danadian,Selma F. Witchel,Silva Arslanian

DOI: https://doi.org/10.1067/mpd.2001.109603

IF: 6.314

2001-01-01

The Journal of Pediatrics

Abstract:OBJECTIVE: To investigate insulin sensitivity and secretion in young adolescent girls with childhood onset polycystic ovarian syndrome (PCOS) and to identify the early metabolic derangement(s).STUDY DESIGN: Twelve obese girls with PCOS (age 12.0+/-0.7 years) were compared with 10 obese nonhyperandrogenic girls (control group). The groups were matched for age, percent body fat, and abdominal fat. All subjects underwent a 3-hour hyperinsulinemic (80 mu/m(2)/min)-euglycemic clamp to determine in vivo insulin sensitivity and a 2-hour hyperglycemic clamp (225 mg/dL) to determine insulin secretion. Fasting hepatic glucose production was determined with the use of [6,6-(2)H(2)]glucose.RESULTS: Fasting glucose and hepatic glucose production were comparable between the 2 groups, but fasting insulin was 2-fold higher in the PCOS group. The fasting glucose to insulin ratio was lower in the PCOS group versus the control group (1.9+/- 0.3 vs 3.1+/-0.3, P =.02). During the hyperinsulinemic-euglycemic clamp, insulin sensitivity was lower in the PCOS group (1.4+/-0.2 vs 2.7+/-0.3 mg/kg/min per microu/mL, P =.002). During the hyperglycemic clamp, insulin secretion was significantly higher in the PCOS group. Insulin sensitivity correlated negatively with fasting insulin (r = -0.71, P =.0002) and positively with the fasting glucose to insulin ratio (r = 0.79, P<.0001).CONCLUSION: Adolescent girls with PCOS have profound metabolic derangements detected early in the course of the syndrome, including (1) approximately 50% reduction in peripheral tissue insulin sensitivity, (2) evidence of hepatic insulin resistance, and (3) compensatory hyperinsulinemia. These observations may predict an increased risk of type 2 diabetes mellitus in adolescents with PCOS.
Evaluation of hematologic and coagulation system disorders in adolescents with polycystic ovary syndrome

Havva Kaya,Elif Kazanci,Ozlem Kara,Deniz Guven

DOI: https://doi.org/10.5455/atjmed.2024.04.04

2024-01-01

The Atlantic Journal of Medical Science and Research

Abstract:Aim: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, ovulatory dysfunction, insulin resistance, and obesity, affects 8-26% of adolescent girls. The effects of polycystic ovarian syndrome on the hematologic and coagulation systems have received little attention. We aimed to investigate the hematologic and coagulation system disorders in PCOS. Materials and Methods: The study included 40 adolescents with PCOS and 41 healthy controls. Hemostatic and coagulation system parameters evaluated in both groups and were compared with metabolic parameters. Results: Adolescent’s with PCOS had a significantly higher insulin, HOMA-IR levels, and Hematocrit (Hct) levels than the control group, but no significant difference was found in D-dimer, fibrinogen, protein C, protein S, Antitrombine III levels. A positive correlation was found between insulin and HOMA-IR values and hemoglobin (Hgb), Hct, white blood cell (WBC) levels (r=0.32 p=0.003; r=0.33 p=0.002; r=0.36 p=0.001, respectively); also a positive correlation was found between high-density lipoprotein cholesterol (HDL) and WBC values (r=0.26 p=0.01). A positive correlation was found between follicle stimulating hormone (FSH) and Protein C and Protein S (r=0.41 p=0.008; r=0.31 p=0.04); total testosterone and fibrinogen levels (r=0, 32 p=0.04); Dehydroepiandrostenedione sulfate (DHEAS) and protein S levels (r=0.31 p=0.04). Conclusion: There was no significant difference in the hematologic and coagulation parameters between PCOS and healthy controls. Hypercoagulated state in PCOS is associated with obesity, BMI, inflammation, and insulin resistance, not specific to the disease.
FRI039 Endothelial Dysfunction Is Associated With Adiponectin And Leptin In Adolescents With PCOS

Irina Gavryutina,Ahmed Badran,Amruta Thakkar,Renee Bargman,Vatcharapan Umpaichitra,Vivian Chin

DOI: https://doi.org/10.1210/jendso/bvad114.050

2023-10-01

Journal of the Endocrine Society

Abstract:Abstract Disclosure: I. Gavryutina: None. A. Badran: None. A. Thakkar: None. R. Bargman: None. V. Umpaichitra: None. V. Chin: None. Endothelial dysfunction (ED) was found to be prevalent in women with polycystic ovarian syndrome (PCOS) and was associated with increased leptin and decreased adiponectin levels but has not been studied in children. We performed a cross-sectional study of non-smoking adolescents aged 12-19 years old with PCOS by NIH-criteria (n=20) and controls (n=7) to study the differences in ghrelin, endothelin, anti-mullerian hormone (AMH), leptin, adiponectin and reactive-hyperemia index (RHI) a non-invasive single measure of ED using EndoPAT®. Exclusion criteria were: pregnancy, diabetes, thyroid disease, adrenal disorder, hepatic, cardiovascular disease, hypertension, or medications (other than metformin or oral contraceptive pills which were allowed for the PCOS group). Between PCOS and control groups, there was no difference (mean±SD) in age (16.5±1.8 vs 17.1±2.3 years, p=0.31), BMI (35.7 ±9.7 vs 30.9±10.3 kg/m2, p=0.15) and A1C levels (5.45±0.4 vs 5.37±0.15%, p=0.22). Total and free testosterone was higher in PCOS group (60.7±21.8 vs 34.6±12.8 ng/dl, p=0.00063; 8.51 vs 3.76, p=0.0019, respectively). PCOS group had worse (lower) RHI (1.26±0.43 vs 1.72±0.40, p=0.015, normal RHI >1.67). PCOS group had higher leptin (1085.5±116.9 vs 896.4±176 pg/ml, p=0.014) and lower adiponectin (2.02±0.19 vs 2.27±0.13 μg/ml, p=0.001). There were no differences in endothelin-1 (10.9±1.2 vs 34.3±3.1 pg/ml, p=0.11), ghrelin (6060.1±13057.2 vs 5495.7±5474 pg/dl, p=0.44) and AMH levels (11.86±27 vs 3.8±10.1, p=0.14). HOMA-IR or insulin resistance was not significantly different between the PCOS and control groups (2.05 vs 3.48, p=0.26). Leptin is a proinflammatory product of adipose tissue and via its receptor on the endothelium, likely promotes platelet aggregation, thrombosis and stimulation of free radical production contributing to ED. Adiponectin on the other hand, is known to reduce levels of TNFα and suppress its inflammatory effects on endothelial cells. Low adiponectin has previously been found in women with PCOS when corrected for BMI and even insulin resistance. Our adolescents with PCOS had lower RHI, higher leptin and lower adiponectin levels. These findings suggest increased risk of cardiovascular disease in adolescents which has not been previously reported in children before. Further studies are needed to investigate the relationship between ED and differences in leptin and adiponectin in adolescents with PCOS. Presentation: Friday, June 16, 2023
Metabolic characteristics of polycystic ovary syndrome patients with different body mass index and clinical phenotypes

Jiayi Liu,Shanmei Shen,Jing Wang,Bingjie Zhang,Fei Shao,Yandong Cheng,Ran Meng,Yali Jing,Wenhuan Feng,Qijun Fang,Yan Bi,Dalong Zhu

DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2018.03.011

2018-01-01

Abstract:Objective To analyze the endocrine and metabolic characteristics of patients with polycystic ovary syndrome(PCOS)with different body mass indexes(BMI)and clinical phenotypes,so as to provide some new clues for the individualized and comprehensive clinical management of PCOS. Methods A total of 388 PCOS patients from December 2012 to December 2016 and 66 women with regular menstruation and normal androgen level matched with age and BMI were enrolled in this study.The PCOS patients were further divided into obese group and non-obese group according to their BMI,or were divided into four subgroups according to their clinical manifestations based on the 2003 Rotterdam criteria:oligo-and/or anovulation(O)+hyperandrogenism(H),O+polycystic ovary morphology(P),H+P and O+H+P. According to the status of hyperandrogenism, the PCOS patients were also divided into two subgroups:hyperandrogenism group (HA) and non-hyperandrogenism group (non-HA). The hormones and metabolic parameters were compared between different groups. Spearman correlation analysis was used for analyzed the association among sex hormones and glucose, lipid and uric acid metabolism and other related indicators.Results (1)There were significant differences in hormones and metabolic parameters between obese group and non-obese group(all P<0.05).The fasting insulin(FINS)in OH,HP and OHP group was significantly higher than that in control group[(20±13),(21±13),(22±15)vs(15±10)mU/L,all P<0.05].The serum FINS level in OHP group was significantly higher than that in OP group[(22±15)vs(17±12)mU/L, P<0.05]. Homeostasis model assessment-insulin resistance (HOMA-IR) in OHP group was significantly higher than that in control group (5.2 ± 3.9 vs 3.4 ± 2.4, P<0.05). (2) The serum level of high density lipoprotein-cholesterol(HDL-C)in OH group,HP group and OHP group was significantly lower than that in control group.The serum level of low density lipoprotein-cholesterol(LDL-C)in HP group was significantly higher than that in control group and OP group(all P<0.05).(3)The differences in BMI,FINS,postprandial insulin,HOMA-IR,HDL-C and sex hormone binding globulin(SHBG)between HA group and non-HA group [(28±6)vs(26±6)kg/m2,(22±14)vs(17±12)mU/L,(153±111)vs(121±88)mU/L,5±4 vs 4±3,(1.1±0.3)vs (1.2±0.3)mmol/L,(22±13)vs(41±23)nmol/L,t=-2.805-3.891]were significant(all P<0.05).(4)SHBG was negatively correlated with fasting plasma glucose, FINS, HOMA-IR, serum uric acid (SUA), triglyceride (TG), LDL-C (r=-0.233--0.147,all P<0.05), and was positively correlated with HDL-C (r=0.384, P<0.001).Free androgen index was positively correlated with FINS,HOMA-IR,SUA,TG(r=0.143-0.231,all P<0.05),and was negatively correlated with HDL-C(r=-0.160,P=0.012).Conclusion Hyperandrogenism and obesity may increase the risk of endocrine and metabolic disorders in PCOS patients. PCOS patients with different clinical phenotypes have different endocrine and metabolic characteristics.
Lean mass and associated factors in women with PCOS with different phenotypes

Tayane Muniz Fighera,Betânia Rodrigues Dos Santos,Poli Mara Spritzer

DOI: https://doi.org/10.1371/journal.pone.0292623

IF: 3.7

2023-10-05

PLoS ONE

Abstract:Although current evidence suggests increased risk of obesity, insulin resistance, and metabolic alterations in patients with polycystic ovary syndrome (PCOS), especially of a hyperandrogenic phenotype, the impact of each one of these variables on muscle mass remains uncertain. In this case-control study, we evaluated clinical and hormonal characteristics related to lean body mass according to the different PCOS phenotypes. We performed clinical, metabolic, and hormonal assessments and evaluated body compartments by dual-energy X-ray absorptiometry in 133 women of reproductive age. Creatinine served as an indirect marker of lean mass. Median age was 28 (range, 17-37) years. Women with phenotypes A and B (n = 59) had higher body mass index (BMI) and metabolic syndrome prevalence than those with phenotype C (n = 23) and controls (n = 51) (p<0.005). Women with phenotypes A and B also had higher Ferriman-Gallwey score (p<0.001), insulin levels (p = 0.006), HOMA-IR (p = 0.008), testosterone (p = 0.008), free androgen index (FAI) (p<0.001), fat mass index (FMI) (p = 0.015), android-to-gynoid fat ratio (p = 0.036), and bone mineral density (BMD) at lumbar spine (p = 0.027) and total femur (p = 0.013) than controls. Median appendicular lean mass index (ALMI) was higher in phenotypes A and B than in controls (7.01 [IQR, 6.33-8.02] vs. 6.69 [IQR, 5.94-7.09], p = 0.024), but it did not differ significantly from that in phenotype C (6.60 [IQR, 6.16-7.22], p = 0.222). Even after adjusting for BMI, ALMI correlated positively with creatinine in women with phenotypes A and B (rho = 0.319, p = 0.023) but not in those with phenotype C (p = 0.238) or controls (p = 0.097). In multivariate linear regression analyses, ALMI was positively associated with insulin, FAI, FMI, and total femur BMD. The present results suggest that fasting insulin, FAI, fat mass, and total femur BMD were positively associated with increased lean mass in women with PCOS phenotypes A and B.
Activation of Systemic Inflammation and Oxidative Stress in Adolescent Girls with Polycystic Ovary Syndrome in Combination with Metabolic Disorders and Excessive Body Weight

Elena Khashchenko,Mikhail Vysokikh,Elena Uvarova,Lyubov Krechetova,Valentina Vtorushina,Tatyana Ivanets,Maria Volodina,Nadezhda Tarasova,Iuliia Sukhanova,Gennady Sukhikh

DOI: https://doi.org/10.3390/jcm9051399

IF: 3.9

2020-05-09

Journal of Clinical Medicine

Abstract:Relevance: Mitochondrial dysfunction and systemic inflammation are believed to play pivotal role in the pathogenesis of polycystic ovary syndrome (PCOS) and related complications of metabolic disorders in adult patients. Though such researches are limited or almost absent in adolescents. The aim of the study is to evaluate the impact of mitochondrial dysfunction and systemic inflammation on PCOS pathogenesis during adolescence with regard to body mass index and insulin resistance. Design: a case-control study. Methods: The study included 95 adolescent girls (15 to 17 years old inclusive) diagnosed with PCOS based on the Rotterdam criteria. The control group consisted of 30 healthy girls of the same age with a regular menstrual cycle. All participants were subjected to a full clinical and instrumental examination, as well as an assessment of the levels of leptin, C-reactive protein (CRP), and malondialdehyde (MDA) as oxidative stress marker. Serum levels of IL-6, IL-10, IL-18, TNF-α, and plasma concentrations of macrophage migration inhibitory factor (MIF), sFas, and sFasL were determined. Patients with PCOS were divided into groups according to the presence of metabolic disorders (MD) (impaired glucose tolerance and/or over insulin resistance) and normal weight or excessive weight (NW or OW). Results: Patients with PCOS of NW in the absence of metabolic disorders (MD−/NW) had a lower concentration of MDA and a higher level of IL-10 compared to healthy girls (p < 0.05). The group (MD−/NW) was characterized with lower levels of CRP, leptin, MDA, and higher levels of sFasL, when compared to OW patients with PCOS in the absence of metabolic disorders (MD−/OW) (p < 0.05). Overweight adolescent girls with PCOS and metabolic disorders (MD+/OW) showed higher CRP, leptin, and a two-fold increase in IL-6 and IL-18 concentrations compared to the control group of healthy girls (p < 0.05 for all parameters). The group (MD+/OW) was also characterized with higher levels of CRP, leptin, MDA, IL-18, MIF (p < 0.05), when compared to overweight patients with PCOS in the absence of metabolic disorders (MD−/NW). In comparison with the MD−/OW group, the obese insulin resistant girls with PCOS (MD+/OW) had a highera level of IL-18 (p < 0.05). Moreover, the MD+/OW girls demonstrated a significant increase in CRP, MDA and IL-18 levels when compared to the MD+/NW group (p < 0.05). OW girls with PCOS without MD (MD−/OW) had lower concentrations of sFasL compared to healthy girls (p < 0.05), and higher levels of MDA compared to MD+/NW (p < 0.05). Adolescent girls of NW with PCOS and with MD (MD+/NW) had lower levels of MDA compared to the control group of healthy girls (p < 0.05). These data are confirmed by a correlation analysis and two-factor ANOVA test. Conclusions: Lean girls with PCOS demonstrate the protective mechanism of decrease in oxidative stress mediated by the activation of antioxidant defense, reduction of lipid peroxidation and systemic inflammation. Excessive weight and metabolic disorders in adolescents with PCOS are the most significant factors in reducing the capacity of antioxidant systems, activation of oxidative stress, mitochondrial dysfunction, and systemic inflammation.

medicine, general & internal
Association Between Vitamin D and Metabolic Indexes in Patients with Polycystic Ovary Syndrome

Shen Shanmei,Liu Jiayi,Li Yikun,Qiao Chengcheng,Yang Jiamiao,Yan Bi,Dalong Zhu

DOI: https://doi.org/10.2337/db18-2453-pub

IF: 7.7

2018-01-01

Diabetes

Abstract:Objective: The aim of this study was to investigate the effect of vitamin D on the metabolic characteristics of polycystic ovary syndrome(PCOS) and its mechanism. Methods and Results: 155 cases of PCOS patients and 74 non-PCOS women withmatched age and BMI were enrolled in this study.Data were collected from May 2016 to November 2017. Plasma 25-hydroxyvitamin D[25(OH)D], metabolic markers, and sex hormones were measured. Homeostasis model assessment(HOMA-IR), triglyceride(TG), testosterone(T), free androgen index(FAI) and uric acid(UA) were significantly increased(P<0.05) while 25-(OH)D, high-density lipoprotein cholesterol (HDL-C) and sex hormone binding globulin(SHBG) were lower(P<0.05) in PCOS than non-PCOS. Body mass index(BMI), fasting plasma insulin(FINS), HOMA-IR, TG, total cholesterol(TC) and T,FAI were higher(P<0.05) in Low-Vitamin D group than High-Vitamin D group. Postprandial plasma glucose(PPG) and postprandialplasma insulin(PINS) were higher(P<0.05) in Low-Vitamin D group than both High-Vitamin D group and Middle-Vitamin D group. Vitamin D was associated with BMI(r=-0.265, P=0.002), SBP(systolic blood pressure)(r=-0.267, P=0.002), HOMA-IR(r=-0.265, P=0.001),PINS(r=-0.252, P=0,002), TG(r=-0.265, P=0.001) and FAI(r=-0.211, P=0.027) in women with PCOS. However, after BMI was adjusted, vitamin D was no longer associated with these indexes. Vitamin D inoverweight/obese women with PCOS was lower than normal-weight women(P<0.05). Vitamin D was associated with DBP(r=-0.746,P=0.021) in overweight women with PCOS and was associated with PINS(r=-0.405,P=0.001)in obese women with PCOS. Conclusion: Serum level of vitamin D was lower in women with PCOS than controls. Vitamin D in overweight/obese women with PCOS was lower than normal-weight women with PCOS. Vitamin D is associated with insulin resistance and cardiovascular disease risk in overweight/obese women with PCOS. Disclosure S. Shanmei: None. L. Jiayi: None. L. Yikun: None. Q. Chengcheng: None. Y. Jiamiao: None. Y. Bi: None. D. Zhu: None.
Diabetes Mellitus Type 2 Patients with Abdominal Obesity Are Prone to Osteodysfunction: A Cross-Sectional Study

Hui Guo,Zengmei An,Ningjian Wang,Shaohong Ge,Jian Cai,Shiyan Yu,Ying Zhou,Rong Ying,Kexi Zha,Tao Gu,Yan Zhao,Yingli Lu

DOI: https://doi.org/10.1155/2023/3872126

IF: 4.0608

2023-04-19

Journal of Diabetes Research

Abstract:Introduction. The interaction between diabetes, obesity, and bone metabolism was drawing increasing public attention. However, the osteometabolic changes in diabetes mellitus type 2 (T2DM) patients with abdominal obesity have not been fully revealed. This study is aimed at investigating the association between abdominal obesity indices and bone turnover markers among T2DM participants. Methods. 4351 subjects were involved in the METAL study. Abdominal obesity indices included neck, waist, and hip circumference, visceral adiposity index (VAI), lipid accumulation product (LAP), waist-to-hip ratio (WHR), and Chinese visceral adiposity index (CVAI). They were applied to elucidate the nexus between β-C-terminal telopeptide (β-CTX), osteocalcin (OC), and intact N-terminal propeptide of type I collagen (P1NP). Results. Abdominal obesity indices were strongly negatively associated with β-CTX and OC. Among males, five indices were negatively correlated with β-CTX (BMI, WC, LAP, WHR, and CVAI) and OC (BMI, NC, WC, WHR, and CVAI). There were no significant associations with P1NP. Among females, all eight indices were negatively associated with β-CTX. Seven indices were negatively related to OC (BMI, NC, WC, HC, LAP, WHR, and CVAI). The VAI was negatively correlated with P1NP. Conclusions. The present study demonstrated that in T2DM, abdominal obesity had an obviously negative correlation with bone metabolism. Abdominal obesity indices were significantly negatively associated with skeletal destruction (β-CTX) and formation (OC). In routine clinical practice, these easily obtained indices could be used as a preliminary screening method and relevant factors for osteodysfunction incidence risk at no additional cost and may be of particular value for postmenopausal women in T2DM populations.

endocrinology & metabolism,medicine, research & experimental
Associations of Childhood Adiposity and Cardiometabolic Biomarkers With Adolescent PCOS

Rachel C. Whooten,Sheryl L. Rifas-Shiman,Wei Perng,Jorge E. Chavarro,Elsie Taveras,Emily Oken,Marie-France Hivert

DOI: https://doi.org/10.1542/peds.2023-064894

2024-04-18

PEDIATRICS

Abstract:OBJECTIVE: Polycystic Ovary Syndrome (PCOS) is common among females, with significant metabolic and reproductive comorbidities. We describe PCOS development in a pediatric population. METHODS: We assessed cardiometabolic biomarkers and adiposity at the midchildhood (mean 7.9 y), early teen (mean 13.1 y), and midteen (mean 17.8 y) visits among 417 females in the prospective Project Viva cohort. We defined PCOS via self-reported diagnosis or ovulatory dysfunction with hyperandrogenism in midlate adolescence. We used multivariable logistic regression to assess associations of metabolic and adiposity markers at each visit with PCOS. RESULTS: Adolescents with PCOS (n = 56, 13%) versus without had higher mean (SD) BMI z-score and truncal fat mass at the midchildhood (0.66 [0.99] vs 0.30 [1.04]; 3.5 kg [2.6] vs 2.7 [1.5]), early teen (0.88 [1.01] vs 0.25 [1.08]; 9.4 kg [6.7] vs 6.1 [3.4]), and midteen (0.78 [1.03] vs 0.33 [0.97]; 11.6 kg [7.2] vs 9.1 [4.9]) visits as well as lower adiponectin to leptin ratio at the early (0.65 [0.69] vs 1.04 [0.97]) and midteen (0.33 [0.26] vs 0.75 [1.21]) visits. In models adjusted for maternal PCOS, education and child race and ethnicity (social factors), we found higher odds of PCOS per 1-SD increase in truncal fat at midchildhood (odds ratio [OR] 1.42; 95% confidence interval [CI] 1.03–1.95) and early teen visits (OR 1.61; 95% CI 1.14–2.28) and lower odds per 1-SD increase in adiponectin/leptin ratio at the midteen visit (OR 0.14; 95% CI 0.03–0.58). CONCLUSIONS: Childhood excess adiposity and adipose tissue dysfunction may be a first signs of later PCOS risk.

pediatrics
Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)

Farnaz Kamali Haghighi Shirazi,Zohre Khodamoradi,Marjan Jeddi

DOI: https://doi.org/10.1186/s12902-021-00710-z

2021-03-09

BMC Endocrine Disorders

Abstract:Abstract Background Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy among young women. Insulin resistance is a key feature in the pathogenesis of PCOS; also high molecular weight adiponectin is a marker of insulin resistance. The aim of this study was to evaluate the insulin resistance, metabolic and androgenic profiles and high molecular weight adiponectin in obese and non-obese PCOS patients. Methods In this cross-sectional study in outpatient endocrinology clinics of Shiraz University of Medical Sciences, 80 women aged 17–43 years old with PCOS were enrolled. Biochemical and hormonal assay was done on fasting blood sample on the third day of follicular phase. Results The individuals had a mean age of 28.39 ± 6.56 years, mean weight of 65.41 ± 12.59 Kg, mean BMI of 25.5 ± 4.9, and mean waist circumference of 88.0 ± 13.1 cm. Of all individuals 20% had frank insulin resistance with HOMA-IR > 3.8. Although the obese PCOS patients had lower levels of high molecular weight adiponectin ( P = 0.03) than the normal weight PCOS individuals, the level of insulin and insulin resistance was not different in them ( P = 0.13, 0.13). Patients with classic PCOS phenotype significantly had higher levels of insulin resistance and free androgen index ( P < 0.001, 0.001). We found a significant correlation between the insulin level and free androgen index (correlation coefficient: 0.266 and P = 0.018) after adjusting for BMI. Conclusion This cross-sectional study showed a high incidence of insulin resistance in PCOS patients independent of obesity, and determined BMI related lower level of high molecular weight adiponectin in obese PCOS individuals. More detailed studies are warranted for evaluation of insulin resistance and its pathophysiologic role in PCOS.

endocrinology & metabolism

Increasing Access to Naloxone and Legal Issues

Bone metabolism and insulin resistance in obese children

[Isolation of an anti-rickets compound formed during the action of floridin on cholesterol].

Contrasting Bone Profiles in PCOS Are Related to BMI: A Systematic Review and Meta-analysis

Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome

Altered Vitamin D Status and Bone Mineral Density in Obese and Non-obese Patients With Polycystic Ovary Syndrome: A Cross-Sectional Study in Turkey

Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health

Marrow adipose tissue is increased in overweight and obese women with PCOS independently of hyperandrogenism related obesity and metabolic disorders

Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis

Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome

Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome

Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome

Evaluation of hematologic and coagulation system disorders in adolescents with polycystic ovary syndrome

FRI039 Endothelial Dysfunction Is Associated With Adiponectin And Leptin In Adolescents With PCOS

Metabolic characteristics of polycystic ovary syndrome patients with different body mass index and clinical phenotypes

Lean mass and associated factors in women with PCOS with different phenotypes

Activation of Systemic Inflammation and Oxidative Stress in Adolescent Girls with Polycystic Ovary Syndrome in Combination with Metabolic Disorders and Excessive Body Weight

Association Between Vitamin D and Metabolic Indexes in Patients with Polycystic Ovary Syndrome

Diabetes Mellitus Type 2 Patients with Abdominal Obesity Are Prone to Osteodysfunction: A Cross-Sectional Study

Associations of Childhood Adiposity and Cardiometabolic Biomarkers With Adolescent PCOS

Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)